Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

Open Access 01-12-2020 | Community-Acquired Pneumonia | Research article

Incidence, mortality, and lethality of hospitalizations for community-acquired pneumonia with comorbid cardiovascular disease in Spain (1997–2015)

Authors: Loreto Arias-Fernández, Ruth Gil-Prieto, Ángel Gil-de-Miguel

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

The probability of hospitalization in patients suffering from community-acquired pneumonia (CAP) with an underlying comorbidity, such as a cardiac pathology, is 73-fold higher than that in CAP patients without a comorbidity. Although previous studies have investigated patients with cardiac events and pneumonia, they have not studied the burden of disease in depth at the population level. The objective of this study is to provide population-level data on patients ≥60 years old who were hospitalized with pneumonia with comorbid cardiovascular disease (CVD) in Spain over a period of 19 years (1997–2015).

Methods

This is a retrospective study based on a minimum basic data set (MBDS). The following variables were collected: age, sex, re-admission (yes/no), hospital stay (days), and other diagnoses. Hospitalization rate (per 100,000 inhabitants), mortality rate (per 100,000 inhabitants), and lethality rate (%) were obtained, and the 95% confidence interval of each rate was calculated. Analyses were stratified by age (categorized into 4-year intervals), sex, and year of admission. Differences were assessed for significance with the chi-squared test for proportions and the Poisson model for rates. Logistic regression was run with in-hospital survival as the dependent variable and sex, age, year of admission, and re-admission (yes/no) as the independent variables. The level of significance was p < 0.005.

Results

The total number of patients ≥60 years old hospitalized for pneumonia with comorbid CVD was 99,346. The rates of hospitalization, mortality, and lethality increased significantly with age over the 19 years. Men had higher rates of hospitalization and mortality. The probability of a patient with CAP and CVD dying was correlated with male sex, older age, hospital re-admission, and having been hospitalized earlier in the study period.

Conclusions

Community-acquired pneumonia with comorbid cardiovascular disease continues to be a major cause of hospitalization in Spain, especially in the elderly population, making it necessary to develop more preventive strategies for this group of patients.
Literature
8.
go back to reference Instituto Nacional de Estadística. Defunciones según causa de muerte. Madrid: Notas de prensa; 2017. Instituto Nacional de Estadística. Defunciones según causa de muerte. Madrid: Notas de prensa; 2017.
16.
go back to reference Gil A, San-Martín M, Carrasco PGA. Epidemiology of pneumonia hospitalisations in Spain 1995–1998. J Inf Secur. 2002;44:84–7. Gil A, San-Martín M, Carrasco PGA. Epidemiology of pneumonia hospitalisations in Spain 1995–1998. J Inf Secur. 2002;44:84–7.
17.
go back to reference Gil A, Gil R, Oyagüez I, Carrasco PGA. Hospitalisation by pneumonia and influenza in the 50–64 year old population in Spain (1999–2002). Hum Vaccines. 2006;2:181–4.CrossRef Gil A, Gil R, Oyagüez I, Carrasco PGA. Hospitalisation by pneumonia and influenza in the 50–64 year old population in Spain (1999–2002). Hum Vaccines. 2006;2:181–4.CrossRef
19.
go back to reference Rodríguez del Águila M, Perea-Milla E, Librero J, Buzón Barrera M, Rivas Ruiz F. Análisis del control de calidad del Conjunto Mínimo de Datos Básicos de Andalucía en los años 2000 a 2003. Sevilla; 2004. Rodríguez del Águila M, Perea-Milla E, Librero J, Buzón Barrera M, Rivas Ruiz F. Análisis del control de calidad del Conjunto Mínimo de Datos Básicos de Andalucía en los años 2000 a 2003. Sevilla; 2004.
20.
go back to reference Instituto de Información Sanitaria. Metodología de análisis de la hospitalización en el sistema nacional de salud. Madrid: Modelo de indicadores basado en el registro de altas (CMBD) documento base; 2007. Instituto de Información Sanitaria. Metodología de análisis de la hospitalización en el sistema nacional de salud. Madrid: Modelo de indicadores basado en el registro de altas (CMBD) documento base; 2007.
21.
go back to reference Ernst JM. Who is at risk for influenza? Using criteria other than age. Manag Care. 2000;9:46 48–50, 52–5.PubMed Ernst JM. Who is at risk for influenza? Using criteria other than age. Manag Care. 2000;9:46 48–50, 52–5.PubMed
26.
go back to reference Panorama de la sociedad 2014: Indicadores sociales de la OCDE. La crisis y sus consecuencias/Organización de Cooperación y Desarrollo Económico. Madrid: Ministerio de Empleo y Seguridad Social de España. Subdirección General de Información Administrativa y Publicaciones; 2014. p. 152. Panorama de la sociedad 2014: Indicadores sociales de la OCDE. La crisis y sus consecuencias/Organización de Cooperación y Desarrollo Económico. Madrid: Ministerio de Empleo y Seguridad Social de España. Subdirección General de Información Administrativa y Publicaciones; 2014. p. 152.
27.
go back to reference Centro Nacional de Epidemiología. Casos humanos de infección por nuevo virus de la gripe A (H1N1). Evolución de la situación en España. Boletín Epidemiológico Sem. 2009;17:1–4. Centro Nacional de Epidemiología. Casos humanos de infección por nuevo virus de la gripe A (H1N1). Evolución de la situación en España. Boletín Epidemiológico Sem. 2009;17:1–4.
31.
go back to reference Lorente Antoñanzas R, Varona Malumbres JL, Antoñanzas Villar F, Rejas-Gutierrez J. A dynamic model to estimate the budget impact of a pneumococcal vaccination program in a 65 year-old immunocompetent Spanish cohort with 13-Valent pneumococcal conjugate vaccine. Rev Esp Salud Pública. 2016;90:1–12. Lorente Antoñanzas R, Varona Malumbres JL, Antoñanzas Villar F, Rejas-Gutierrez J. A dynamic model to estimate the budget impact of a pneumococcal vaccination program in a 65 year-old immunocompetent Spanish cohort with 13-Valent pneumococcal conjugate vaccine. Rev Esp Salud Pública. 2016;90:1–12.
33.
go back to reference Redondo E, Rivero-Calle I, Mascarós E, Díaz-Maroto JL, Linares M, Gil Á, et al. El nuevo calendario vacunal oficial del adulto no contempla la prevención de la neumonía neumocócica. Rev Esp Quim. 2019;32:281–3. Redondo E, Rivero-Calle I, Mascarós E, Díaz-Maroto JL, Linares M, Gil Á, et al. El nuevo calendario vacunal oficial del adulto no contempla la prevención de la neumonía neumocócica. Rev Esp Quim. 2019;32:281–3.
34.
go back to reference González-Romo F, Picazo J, García Rojas A, Labrador Horrillo M, Barrios V, Magro M, et al. Consenso sobre la vacunación anti-neumocócica en el adulto por riesgo de edad y patología de base. Actualización 2017. Rev Esp Quim. 2017;30:142–68. González-Romo F, Picazo J, García Rojas A, Labrador Horrillo M, Barrios V, Magro M, et al. Consenso sobre la vacunación anti-neumocócica en el adulto por riesgo de edad y patología de base. Actualización 2017. Rev Esp Quim. 2017;30:142–68.
35.
go back to reference Gobierno de la Rioja. Vacunación Frente a Enfermedad Neumocócica en Rioja. 2017. http://www.riojasalud.es/f/rs/docs/INFORMACION_NEUMOC%C3%93CICA_65A%C3%91 MARZO 2017.pdf. Gobierno de la Rioja. Vacunación Frente a Enfermedad Neumocócica en Rioja. 2017. http://​www.​riojasalud.​es/​f/​rs/​docs/​INFORMACION_​NEUMOC%C3%93CICA_65A%C3%91 MARZO 2017.pdf.
Metadata
Title
Incidence, mortality, and lethality of hospitalizations for community-acquired pneumonia with comorbid cardiovascular disease in Spain (1997–2015)
Authors
Loreto Arias-Fernández
Ruth Gil-Prieto
Ángel Gil-de-Miguel
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05208-y

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue